RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.
about
Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs.Emerging trends in the management of neuropathic pain.Advances in bioresponsive closed-loop drug delivery systems.Comparison of electroencephalographic changes in response to acute electrical and thermal stimuli with the tail flick and hot plate test in rats administered with opiorphin.
P2860
RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
RB101(S), a dual inhibitor of ...... Fos study at the spinal level.
@en
RB101(S), a dual inhibitor of ...... Fos study at the spinal level.
@nl
type
label
RB101(S), a dual inhibitor of ...... Fos study at the spinal level.
@en
RB101(S), a dual inhibitor of ...... Fos study at the spinal level.
@nl
prefLabel
RB101(S), a dual inhibitor of ...... Fos study at the spinal level.
@en
RB101(S), a dual inhibitor of ...... Fos study at the spinal level.
@nl
P2093
P1476
RB101(S), a dual inhibitor of ...... -Fos study at the spinal level
@en
P2093
Bernard Pierre Roques
Jaroslava Buritova
Jean-Marie Besson
Marie-Claude Fournié-Zaluski
Stéphanie Le Guen
P304
P356
10.1016/S0014-2999(01)01497-2
P407
P577
2002-04-01T00:00:00Z